4//SEC Filing
Chanda Sanjay 4
Accession 0000950170-25-003157
CIK 0001880438other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:00 PM ET
Size
5.4 KB
Accession
0000950170-25-003157
Insider Transaction Report
Form 4
Chanda Sanjay
Chief Development Officer
Transactions
- Sale
Common Stock
2025-01-03$1.34/sh−2,957$3,965→ 29,824 total
Footnotes (3)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
- [F2]Includes 20,625 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
- [F3]Includes 2,224 shares purchased on March 31, 2024 under the Issuer's Employee Stock Purchase Plan ("ESPP") and 2,322 shares purchased on September 30, 2024 under ESPP in transactions exempt from reporting under Section 16(b)3.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001571820
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:00 PM ET
- Size
- 5.4 KB